The Barbacid case: why a promise is not yet a cure
Pancreatic cancer is one of the most difficult cancers to treat. For this reason, every new discovery in this field attracts considerable attention, especially when the results appear particularly promising. In recent months, a study led by Mariano Barbacid’s group at the Spanish National Cancer Research Centre sparked significant discussion: a combination of three drugs […]
